Navigation Links
GP's discontented with 48-hour target

In a move to ensure all NHS patients get the opportunity to see a GP within two working days the government is introducing a system of random checks //so as to ensure that GPs are not fiddling around with the appointment times.

The official figures show a high level of observance with the government's two-day target, but concern are being raised that they are not actually reflecting the patients' actual experiences. Critics do argue that this new system will be of little use to.

Many critics argue that the new system will be of limited value as the calls to GP surgeries will not be anonymous. The doctors on their part feel that these targets have reduced their ability to prioritise the patient according to the clinical needs.

It was explained that under the new system, primary care trusts (PCTs) would telephone the surgeries on a random day every month to find out whether they are sticking to the two-day target. It was said that the practises would ask about not only when their first free slot would be available but also when their third slot was, so that they could gauge the depth of accessibility.

The GP's right now get to know ell in advance as to when they would be called by their PCT, leading to growing concerns that the GP are able to schedule their bookings around the call so as to give the impression of meeting the two-day target, which might be easily missed during the rest of the month.

Health Minister Lord Warner while announcing the new system has said that the access to GPs has improved, and that only a few patients had to now wait a week or more to see a doctor. He also said that there have been differences many a times on what the patient has reported and what the records have shown. He said "All patients should have fast access to a GP every working day of the month. At the same time, practices need to offer advance appointments. There must be no excuses or exceptions."

Dr Hamish
'"/>




Page: 1 2

Related medicine news :

1. Feeding channel created by malaria parasite - a new target for malaria treatments
2. Enzyme may be target for obesity drugs
3. Scios Inc. targets drug giants in arthritis war
4. Pharmaceutical companies are targeting patients
5. New target for antidiabetic agents identified
6. Ceramide can target and kill cancer cells
7. Multi targeted approach required for suicide prevention in adolescents
8. Maori diabetes project way off target
9. Microcapsules target cancer cells
10. Indian American Scientist at Work on Multi-targeted Drug
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: discontented with hour target

Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3